(Stroke. 1996;27:435-440.)
© 1996 American Heart Association, Inc.
Articles |
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Cerebrovascular Disease
From the Diabetes and Thrombosis Research Group, Division of Medicine, University of Leeds, Leeds General Infirmary; and the Department of Neurology, St James's University Hospital (J. Bamford), Leeds, UK.
Correspondence to Dr A. Catto, Diabetes and Thrombosis Research Group, Division of Medicine, University of Leeds, Leeds General Infirmary, Leeds, LS1 3EX, UK. E-mail andrewc@pathology.leeds.ac.uk.
Background and Purpose There is evidence that an allelic variation in the angiotensin-converting enzyme (ACE) gene may confer an increased risk of vascular disease. The roles of the ACE insertion/deletion polymorphism and circulating ACE levels are unknown in cerebrovascular disease.
Methods We studied an insertion/deletion polymorphism within intron 16 of the ACE gene by polymerase chain reaction and plasma ACE activity in 467 cases of stroke, the pathological type of which was established by cranial CT, and 231 control subjects. ACE genotype and activity were related to stroke type and mortality at 4 weeks and 3 months.
Results No difference in genotype frequency was observed between all subjects with stroke and control subjects or between control subjects and subjects with cerebral infarction or cerebral hemorrhage. Plasma ACE activity was significantly lower in stroke patients at presentation (64.1 IU/L) than in control subjects (79.6 IU/L; P<.0001). Twenty-one patients (4.5%) with cerebral infarction died within 4 weeks and 56 patients (12%) within 3 months. These patients had significantly lower plasma ACE activity than patients who survived. There was some evidence that risk of death within 4 weeks increased with the number of D alleles (P=.02). Among survivors, plasma ACE activity showed a mean increase of 6.9 IU/L (95% confidence interval, 3.0 to 10.8) between levels at presentation and at 3 months (73.6 IU/L), the latter being similar to ACE activity in control subjects.
Conclusions Low ACE activity at stroke presentation and possession of the D allele may be associated with increased risk of early death from acute cerebral infarction.
Key Words: cerebrovascular disorders • genetics • mortality • angiotensin-converting enzymes
This article has been cited by other articles:
 |
|
 |
|
  H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Slowik, W. Turaj, T. Dziedzic, A. Haefele, J. Pera, M. T. Malecki, L. Glodzik-Sobanska, P. Szermer, D. A. Figlewicz, and A. Szczudlik DD genotype of ACE gene is a risk factor for intracerebral hemorrhage Neurology, July 27, 2004; 63(2): 359 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Wardlaw, P.A.G. Sandercock, M.S. Dennis, J. Starr, and H. Kalimo Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? Stroke, March 1, 2003; 34(3): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-S Uhm, H-S Lee, Y-H Chung, T-H Kim, S-C Bae, K-B Joo, T-Y Kim, and D-H Yoo Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE Lupus, April 1, 2002; 11(4): 227 - 233. [Abstract] [PDF]
|
|
|
|
 |
|
 A Hassan, A Lansbury, A J Catto, A Guthrie, J Spencer, C Craven, P J Grant, and J M Bamford Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 343 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. WALTHER, L. OLAH, C. HARMS, B. MAUL, M. BADER, H. HORTNAGL, H.-P. SCHULTHEISS, and G. MIES Ischemic injury in experimental stroke depends on angiotensin II FASEB J, February 1, 2002; 16(2): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Coutard, W. Huang, M. Osborne-Pellegrin, and H. A. Kontos Heritability of Intracerebral Hemorrhagic Lesions and Cerebral Aneurysms in the Rat Editorial Comment Stroke, November 1, 2000; 31(11): 2678 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassan and H. S. Markus Genetics and ischaemic stroke Brain, September 1, 2000; 123(9): 1784 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Keramatipour, R. S McConnell, P. Kirkpatrick, S. Tebbs, R. A Furlong, and D. C Rubinsztein The ACE I allele is associated with increased risk for ruptured intracranial aneurysms J. Med. Genet., July 1, 2000; 37(7): 498 - 500. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Agerholm-Larsen, B. G. Nordestgaard, and A. Tybjarg-Hansen ACE Gene Polymorphism in Cardiovascular Disease : Meta-Analyses of Small and Large Studies in Whites Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Notsu, T. Nabika, H.-Y. Park, J. Masuda, and S. Kobayashi Evaluation of Genetic Risk Factors for Silent Brain Infarction Stroke, September 1, 1999; 30(9): 1881 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y.L. Zee, P. M. Ridker, M. J. Stampfer, C. H. Hennekens, and K. Lindpaintner Prospective Evaluation of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of Stroke Circulation, January 26, 1999; 99(3): 340 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kario, T. Matsuo, H. Kobayashi, N. Kanai, S. Hoshide, T. Mitsuhashi, U. Ikeda, S. Nishiuma, M. Matsuo, and K. Shimada Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients J. Am. Coll. Cardiol., August 1, 1998; 32(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chapman, N. Wang, T. A. Treves, A. D. Korczyn, and N. M. Bornstein ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia Stroke, July 1, 1998; 29(7): 1401 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huang, F. A. Gelas, and M. J. Osborne-Pellegrin Protection of the Arterial Internal Elastic Lamina by Inhibition of the Renin-Angiotensin System in the Rat Circ. Res., May 4, 1998; 82(8): 879 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sharma Meta-analysis of the ACE gene in ischaemic stroke J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 227 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Watanabe, T. Ishigami, Y. Kawano, T. Umahara, A. Nakamori, S. Mizushima, K. Hibi, I. Kobayashi, K. Tamura, H. Ochiai, et al. Angiotensin-Converting Enzyme Gene I/D Polymorphism and Carotid Plaques in Japanese Hypertension, September 1, 1997; 30(3): 569 - 573. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Heywood, A. M. Carter, A. J. Catto, J. M. Bamford, and P. J. Grant Polymorphisms of the Factor VII Gene and Circulating FVII:C Levels in Relation to Acute Cerebrovascular Disease and Poststroke Mortality Stroke, April 1, 1997; 28(4): 816 - 821. [Abstract] [Full Text]
|
|